An Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Latest Information Update: 14 Dec 2022
At a glance
- Drugs Teicoplanin (Primary) ; Teicoplanin; Teicoplanin
- Indications Methicillin-resistant Staphylococcus aureus infections; Staphylococcal infections
- Focus First in man; Pharmacokinetics
- Sponsors Neupharma
Most Recent Events
- 04 Dec 2020 Status changed from recruiting to completed.
- 21 Nov 2019 Status changed from planning to recruiting.
- 02 Aug 2019 New trial record